Home » Newsletters » BioWorld Science

BioWorld Science

March 3, 2003

View Archived Issues

4SC and Boehringer Ingelheim sign drug discovery agreement

New series of antifungal azoles in early development at Aventis

BioTie researchers present new inhibitors of VAP-1 SSAO

New inhibitors of glyceraldehyde-3-phosphate dehydrogenase and their use in cancer

Ortho-McNeil patent covers antiepileptic topiramate salts

Inhibitors of aP2 and their use in diabetes and lipid disorders claimed by BMS

Exelixis and Protein Design Labs' cancer antibody research collaboration progresses

Albany Molecular Research provides chemistry expertise to Affinium

Progress on several fronts at Amersham

Efficacy reported for G-3139-containing chemotherapy in refractory/relapsed acute leukemia

AGI-1067 equally effective and safer than probucol after PCI

Novel anti-HCV NS3 protease agents presented by Vertex

Novel NK1 antagonists and their use covered by Solvay patent

New tetracyclines discovered by Paratek scientists

FDA approves Oxytrol for overactive bladder

Chiron plans U.S.-based phase III trial for Menjugate

Medarex and Ferric collaborate on therapeutic antibody development

SkyePharma achieves proof of principle for Biosphere technology

Microscience's oral typhoid vaccine is safe and immunogenic

Emisphere reports phase IIa data for oral calcitonin

Shire licenses MethyPatch from Noven

P2Y2 agonists and their potential in vaginal dryness in postmenopausal women

Variations in the efficacy of TNP-470 according to the time of day administered

Inhibitor of NFkB activation suppresses growth of hormone-refractory prostate cancer

Anxiolytic-like effects without sedation or ataxia observed for DMP-696 in rats

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...